Literature DB >> 10473056

Retrograde drilling of osteochondral lesions of the medial talar dome.

W S Taranow1, G A Bisignani, J D Towers, S F Conti.   

Abstract

Sixteen patients (16 ankles) with symptomatic osteochondral lesions of the medial talar dome were treated arthroscopically with percutaneous retrograde drilling through the sinus tarsi. The surgical technique allows preservation of intact articular cartilage, in contrast to traditional methods. All patients treated with this technique during a 24-month period were included in the study. Patient age ranged from 16 to 44 years (mean, 33 years). Follow-up ranged from 19 to 38 months (mean, 24 months). A staging system based on magnetic resonance imaging examination was used to grade the lesions preoperatively. Outcome was evaluated using the American Orthopaedic Foot and Ankle Society Ankle-Hindfoot Scale. Preoperative scores ranged from 35 to 75 points, with a mean of 53.9 points. Postoperative American Orthopaedic Foot and Ankle Society scores ranged from 48 to 100 points, with a mean of 82.6 points. Mean improvement was 25 points. There were no surgical complications. Short-term results were comparable to results reported with other available techniques.

Entities:  

Mesh:

Year:  1999        PMID: 10473056     DOI: 10.1177/107110079902000802

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  23 in total

1.  Arthroscopic autologous chondrocyte implantation in the ankle joint.

Authors:  Sandro Giannini; Roberto Buda; Alberto Ruffilli; Marco Cavallo; Gherardo Pagliazzi; Maria Chiara Bulzamini; Giovanna Desando; Deianira Luciani; Francesca Vannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-01       Impact factor: 4.342

2.  Computer aided surgery in foot and ankle: applications and perspectives.

Authors:  Martinus Richter
Journal:  Int Orthop       Date:  2013-05-25       Impact factor: 3.075

3.  High-resolution MR imaging of talar osteochondral lesions with new classification.

Authors:  James Francis Griffith; Domily Ting Yi Lau; David Ka Wai Yeung; Margaret Wan Nar Wong
Journal:  Skeletal Radiol       Date:  2011-08-09       Impact factor: 2.199

4.  Bony periosteum-covered iliac crest plug transplantation for severe osteochondral lesions of the talus: a modified mosaicplasty procedure.

Authors:  André Leumann; Victor Valderrabano; Martin Wiewiorski; Alexej Barg; Beat Hintermann; Geert Pagenstert
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-07-13       Impact factor: 4.342

5.  [Navigated retrograde drilling in Osteochondrosis dissecans (OCD) of the talus].

Authors:  M Richter; S Zech
Journal:  Oper Orthop Traumatol       Date:  2011-12       Impact factor: 1.154

6.  Potential pitfall in the microfracturing technique during the arthroscopic treatment of an osteochondral lesion.

Authors:  Christiaan J A van Bergen; Peter A J de Leeuw; C Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-09-23       Impact factor: 4.342

7.  MRI-guided percutaneous retrograde drilling of osteochondritis dissecans of the talus: a feasibility study.

Authors:  Pekka Kerimaa; Risto Ojala; Juha-Jaakko Sinikumpu; Pekka Hyvönen; Jussi Korhonen; Paula Markkanen; Osmo Tervonen; Roberto Blanco Sequeiros
Journal:  Eur Radiol       Date:  2014-04-17       Impact factor: 5.315

8.  [Navigated Iso-C(3D)-based drilling of a osteochondral lesion of the talus].

Authors:  D Kendoff; J Geerling; L Mahlke; M Citak; M Kfuri; T Hüfner; C Krettek
Journal:  Unfallchirurg       Date:  2003-11       Impact factor: 1.000

Review 9.  Treatment principles for osteochondral lesions in foot and ankle.

Authors:  Thanos Badekas; Maria Takvorian; Nikolaos Souras
Journal:  Int Orthop       Date:  2013-08-28       Impact factor: 3.075

Review 10.  Treatment of osteochondral lesions of the talus: a systematic review.

Authors:  Maartje Zengerink; Peter A A Struijs; Johannes L Tol; Cornelis Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-27       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.